A673 Cells

The A673 cell line is a valuable resource in biological science. Derived from the muscle tissue of a 15-year-old female patient diagnosed with Ewings Sarcoma, this cell line exhibits a distinct polygonal morphology. Originally the cell line was thought to be derived from a rhabdomyosarcoma (RMS). One of the remarkable characteristics of A673 cells is their ability to produce several growth factors that possess oncogenic potential. These cells also secrete growth-inhibitory factors, providing a balanced environment for cellular growth regulation. Such properties make A673 cells an excellent model for investigating the interplay between tumour-promoting and tumour-suppressing factors. A673 cells have demonstrated tumorigenic potential, as they can induce tumour formation in immunosuppressed mice. Moreover, studies have identified hypermethylated promoters in cancer-related genes within the A673 cell line. These genetic alterations further contribute to its relevance in cancer research, offering a platform to explore epigenetic modifications and their impact on tumour development and progression. While A673 cells are often referred to as Ewing tumour (ET) or sarcoma (ES), they are also associated with rhabdomyosarcoma (RMS). Notably, the A673 cell line harbours a complex karyotype with a specific translocation involving chromosomes 11 and 22. This translocation leads to the fusion of the EWS and FLI1 genes, which is a characteristic genetic event in Ewing Tumor. Bone cancer cell lines, Bone, Ewing's Sarcoma, Growth Conditions: Monolayer, adherent, Biosafety level: BSL 1